TVGN

Tevogen Bio Holdings Inc.

0.75 USD
+0.04 (+5.41%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Tevogen Bio Holdings Inc. stock is up 6.57% since 30 days ago. The next earnings date is Aug 20, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 66.67% of the previous 2 July’s closed higher than June.

About Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc. operates as a clinical-stage biotechnology company that develops off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Its lead investigational precision T cell product, TVGN 489, is designed to address the unmet need of acute-risk COVID-19 patients, as well as a subset of patients suffering from long COVID. The company was founded in 2020 and is based in Warren, New Jersey.